Sleep Pharmaceuticals Jazz Pharmaceuticals Presents Latest Advancements at World Sleep 2023 October 18, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Promising Results for Pitolisant in Prader-Willi Syndrome October 10, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Jazz Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023 September 12, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Promising Results for Narcolepsy Type 1 Treatment, but Safety Concerns Arise July 28, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Avadel Pharmaceuticals Receives FDA Approval of Bedtime Narcolepsy Treatment May 2, 2023 RTSleepWorld Read Article
News ApniMed Secures $80 Million for Apnea Pill Phase 3 Trials January 3, 2023 RTSleepWorld Read Article
News Apnimed OSA Pill Completes Positive Phase 2 Clinical Trials October 17, 2022 RTSleepWorld Read Article
Sleep Pharmaceuticals Eisai to Present New Data On Lemborexant at SLEEP 2022 June 3, 2022 RTSleepWorld Read Article
Sleep Pharmaceuticals Jazz to Present New Data at SLEEP 2022 Reinforcing Leadership in Sleep Medicine June 3, 2022 RTSleepWorld Read Article
Sleep Pharmaceuticals Idorsia Receives FDA Approval of QUVIVIQ for Insomnia January 14, 2022 RTSleepWorld Read Article